NLSCX
Price
$18.92
Change
+$0.02 (+0.11%)
Updated
Aug 21 closing price
Net Assets
7.28B
WRAAX
Price
$14.73
Change
+$0.06 (+0.41%)
Updated
Aug 21 closing price
Net Assets
247.02M
Interact to see
Advertisement

NLSCX vs WRAAX

NLSCX vs WRAAX Comparison Chart in %
View a ticker or compare two or three
VS
NLSCX vs. WRAAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NLSCX is a Buy and WRAAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NLSCX has more cash in the bank: 7.28B vs. WRAAX (247M). WRAAX pays higher dividends than NLSCX: WRAAX (0.11) vs NLSCX (0.00). NLSCX was incepted earlier than WRAAX: NLSCX (15 years) vs WRAAX (15 years). NLSCX (2.38) is less costly to investors than WRAAX (2.01). WRAAX is a more actively managed with annual turnover of: 66.00 vs. NLSCX (0.96). NLSCX (1000) and WRAAX (1000) have matching initial minimum investment requirements. WRAAX annual gain was more profitable for investors over the last year : 6.86 vs. NLSCX (1.72). WRAAX return over 5 years is better than : 28.82 vs. NLSCX (10.20).
NLSCXWRAAXNLSCX / WRAAX
Total Expense Ratio2.381.50159%
Annual Report Gross Expense Ratio2.382.01118%
Fund Existence15 years15 years-
Gain YTD0.9074.98918%
Front LoadN/A6%-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets7.28B247M2,947%
Annual Yield % from dividends0.000.11-
Returns for 1 year1.726.8625%
Returns for 3 years17.8527.8964%
Returns for 5 years10.2028.8235%
Returns for 10 years44.6163.5770%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VNM17.870.72
+4.20%
VanEck Vietnam ETF
NRES36.430.73
+2.04%
Xtrackers RREEF Global Natrl Res ETF
GGZ16.510.13
+0.79%
Gabelli Global Small and Mid Cap Value Trust (The)
BSCQ19.570.01
+0.05%
Invesco BulletShares 2026 Corp Bd ETF
RXD14.04-0.31
-2.17%
ProShares UltraShort Health Care